ge healthcare limited
ge healthcare limited Company Information
Company Number
01002610
Next Accounts
Sep 2025
Shareholders
one ge healthcare uk
Group Structure
View All
Industry
Manufacture of basic pharmaceutical products
Registered Address
pollards wood nightingales lane, chalfont st. giles, buckinghamshire, HP8 4SP
Website
www.gehealthcare.co.ukge healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE LIMITED at £370.1m based on a Turnover of £118.8m and 3.11x industry multiple (adjusted for size and gross margin).
ge healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE LIMITED at £1.6b based on an EBITDA of £122.8m and a 13.09x industry multiple (adjusted for size and gross margin).
ge healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE LIMITED at £1.4b based on Net Assets of £759.8m and 1.78x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ge Healthcare Limited Overview
Ge Healthcare Limited is a live company located in buckinghamshire, HP8 4SP with a Companies House number of 01002610. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in February 1971, it's largest shareholder is one ge healthcare uk with a 100% stake. Ge Healthcare Limited is a mature, mega sized company, Pomanda has estimated its turnover at £118.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ge Healthcare Limited Health Check
Pomanda's financial health check has awarded Ge Healthcare Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 3 areas for improvement. Company Health Check FAQs
8 Strong
1 Regular
3 Weak
Size
annual sales of £118.8m, make it larger than the average company (£37m)
£118.8m - Ge Healthcare Limited
£37m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (5.2%)
14% - Ge Healthcare Limited
5.2% - Industry AVG
Production
with a gross margin of 42%, this company has a comparable cost of product (38.3%)
42% - Ge Healthcare Limited
38.3% - Industry AVG
Profitability
an operating margin of 101.4% make it more profitable than the average company (6.8%)
101.4% - Ge Healthcare Limited
6.8% - Industry AVG
Employees
with 446 employees, this is above the industry average (111)
446 - Ge Healthcare Limited
111 - Industry AVG
Pay Structure
on an average salary of £113.5k, the company has a higher pay structure (£67.7k)
£113.5k - Ge Healthcare Limited
£67.7k - Industry AVG
Efficiency
resulting in sales per employee of £266.4k, this is less efficient (£445.7k)
£266.4k - Ge Healthcare Limited
£445.7k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is earlier than average (56 days)
38 days - Ge Healthcare Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 66 days, this is slower than average (34 days)
66 days - Ge Healthcare Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 26 days, this is less than average (102 days)
26 days - Ge Healthcare Limited
102 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (9 weeks)
0 weeks - Ge Healthcare Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 33.4%, this is a lower level of debt than the average (44.8%)
33.4% - Ge Healthcare Limited
44.8% - Industry AVG
GE HEALTHCARE LIMITED financials
Ge Healthcare Limited's latest turnover from December 2023 is £118.8 million and the company has net assets of £759.8 million. According to their latest financial statements, Ge Healthcare Limited has 446 employees and maintains cash reserves of £73 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 118,821,000 | 98,080,000 | 81,147,000 | 79,734,000 | 99,887,000 | 229,160,000 | 247,921,000 | 206,237,000 | 168,479,000 | 152,014,000 | 181,679,000 | 181,614,000 | 183,070,000 | 149,812,000 | 154,628,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 68,922,000 | 49,598,000 | 48,425,000 | 59,782,000 | 82,105,000 | 160,671,000 | 141,529,000 | 132,569,000 | 104,148,000 | 102,380,000 | 112,216,000 | 121,554,000 | 120,277,000 | 89,325,000 | 91,730,000 |
| Gross Profit | 49,899,000 | 48,482,000 | 32,722,000 | 19,952,000 | 17,782,000 | 68,489,000 | 106,392,000 | 73,668,000 | 64,331,000 | 49,634,000 | 69,463,000 | 60,060,000 | 62,793,000 | 60,487,000 | 62,898,000 |
| Admin Expenses | -70,641,000 | -77,444,000 | -23,447,000 | -12,086,000 | 15,244,000 | 153,195,000 | 74,374,000 | 64,292,000 | 54,279,000 | 48,851,000 | 89,394,000 | 122,291,000 | 99,768,000 | 21,520,000 | 197,086,000 |
| Operating Profit | 120,540,000 | 125,926,000 | 56,169,000 | 32,038,000 | 2,538,000 | -84,706,000 | 32,018,000 | 9,376,000 | 10,052,000 | 783,000 | -19,931,000 | -62,231,000 | -36,975,000 | 38,967,000 | -134,188,000 |
| Interest Payable | 26,484,000 | 14,938,000 | 4,949,000 | 6,116,000 | 5,052,000 | 1,194,000 | 1,342,000 | 1,567,000 | 6,020,000 | 3,447,000 | 5,140,000 | 6,024,000 | 9,144,000 | 5,477,000 | 7,510,000 |
| Interest Receivable | 70,305,000 | 15,821,000 | 1,143,000 | 5,538,000 | 5,090,000 | 4,916,000 | 1,481,000 | 20,762,000 | 12,663,000 | 11,516,000 | 11,548,000 | 4,995,000 | 2,743,000 | 85,495,000 | 36,709,000 |
| Pre-Tax Profit | 168,461,000 | 136,814,000 | 66,450,000 | 95,133,000 | 21,302,000 | -79,899,000 | 41,547,000 | 29,184,000 | 32,023,000 | 14,312,000 | -8,101,000 | -68,243,000 | -37,990,000 | 153,184,000 | -28,817,000 |
| Tax | 47,063,000 | -25,000 | -199,000 | -250,000 | -650,000 | -881,000 | 18,404,000 | -18,760,000 | 2,480,000 | ||||||
| Profit After Tax | 215,524,000 | 136,814,000 | 66,450,000 | 95,108,000 | 21,302,000 | -79,899,000 | 41,547,000 | 29,184,000 | 31,824,000 | 14,062,000 | -8,751,000 | -69,124,000 | -19,586,000 | 134,424,000 | -26,337,000 |
| Dividends Paid | 250,000,000 | 120,000,000 | 420,000,000 | 15,000,000 | 106,000,000 | ||||||||||
| Retained Profit | -34,476,000 | 16,814,000 | 66,450,000 | 95,108,000 | -398,698,000 | -79,899,000 | 26,547,000 | 29,184,000 | 31,824,000 | 14,062,000 | -8,751,000 | -175,124,000 | -19,586,000 | 134,424,000 | -26,337,000 |
| Employee Costs | 50,603,000 | 45,142,000 | 44,654,000 | 54,561,000 | 67,133,000 | 66,877,000 | 62,483,000 | 73,506,000 | 86,426,000 | 89,939,000 | 105,999,000 | 116,736,000 | 111,594,000 | 103,309,000 | 75,822,000 |
| Number Of Employees | 446 | 400 | 398 | 695 | 854 | 826 | 851 | 935 | 998 | 903 | 1,294 | 1,423 | 1,408 | 1,348 | 1,323 |
| EBITDA* | 122,842,000 | 128,148,000 | 59,268,000 | 38,937,000 | 16,003,000 | -46,090,000 | 56,195,000 | 25,783,000 | 27,281,000 | 17,286,000 | -1,664,000 | -40,029,000 | -11,639,000 | 71,583,000 | -101,645,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 6,753,000 | 6,342,000 | 7,919,000 | 8,222,000 | 24,151,000 | 49,217,000 | 78,762,000 | 90,439,000 | 110,728,000 | 113,432,000 | 132,914,000 | 148,946,000 | 167,287,000 | 188,900,000 | 211,580,000 |
| Intangible Assets | 51,965,000 | 3,369,000 | 3,595,000 | 4,629,000 | 9,246,000 | 14,882,000 | 20,524,000 | 25,910,000 | 23,727,000 | 11,126,000 | |||||
| Investments & Other | 477,936,000 | 36,260,000 | 36,260,000 | 36,262,000 | 43,065,000 | 43,065,000 | 43,065,000 | 43,065,000 | 45,738,000 | 45,738,000 | 45,738,000 | 45,738,000 | 45,738,000 | 47,101,000 | 251,933,000 |
| Debtors (Due After 1 year) | 100,345,000 | 23,175,000 | 26,493,000 | 24,014,000 | 25,968,000 | 24,878,000 | 25,365,000 | 23,792,000 | 24,826,000 | 23,169,000 | 581,460,000 | 557,000,000 | |||
| Total Fixed Assets | 636,999,000 | 69,146,000 | 74,267,000 | 73,127,000 | 102,430,000 | 132,042,000 | 167,716,000 | 183,206,000 | 205,019,000 | 193,465,000 | 760,112,000 | 751,684,000 | 213,025,000 | 236,001,000 | 463,513,000 |
| Stock & work in progress | 5,019,000 | 3,203,000 | 2,179,000 | 2,284,000 | 3,384,000 | 10,157,000 | 10,521,000 | 10,985,000 | 11,162,000 | 11,147,000 | 12,134,000 | 15,815,000 | 19,230,000 | 17,066,000 | 12,457,000 |
| Trade Debtors | 12,440,000 | 11,353,000 | 7,305,000 | 2,229,000 | 1,601,000 | 1,512,000 | 2,117,000 | 2,863,000 | 3,549,000 | 2,814,000 | 3,147,000 | 4,481,000 | 3,239,000 | 1,846,000 | 2,912,000 |
| Group Debtors | 482,984,000 | 697,402,000 | 805,163,000 | 712,206,000 | 543,692,000 | 789,626,000 | 741,709,000 | 772,844,000 | 748,669,000 | 718,582,000 | 112,445,000 | 136,642,000 | 823,681,000 | 964,876,000 | 844,170,000 |
| Misc Debtors | 3,262,000 | 6,046,000 | 8,993,000 | 4,802,000 | 2,264,000 | 3,840,000 | 3,918,000 | 7,351,000 | 3,773,000 | 6,630,000 | 2,702,000 | 5,109,000 | 9,124,000 | 4,422,000 | 4,094,000 |
| Cash | 73,000 | 63,000 | 60,000 | 559,000 | 5,478,000 | 6,579,000 | 6,089,000 | 6,072,000 | 6,234,000 | 6,057,000 | 6,114,000 | 111,000 | 34,000 | 530,000 | 148,000 |
| misc current assets | 22,220,000 | 782,000 | |||||||||||||
| total current assets | 503,778,000 | 718,067,000 | 823,700,000 | 722,080,000 | 578,639,000 | 811,714,000 | 764,354,000 | 800,897,000 | 773,387,000 | 745,230,000 | 136,542,000 | 162,158,000 | 855,308,000 | 988,740,000 | 863,781,000 |
| total assets | 1,140,777,000 | 787,213,000 | 897,967,000 | 795,207,000 | 681,069,000 | 943,756,000 | 932,070,000 | 984,103,000 | 978,406,000 | 938,695,000 | 896,654,000 | 913,842,000 | 1,068,333,000 | 1,224,741,000 | 1,327,294,000 |
| Bank overdraft | 1,500,000 | 650,000 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 12,531,000 | 18,047,000 | 18,113,000 | 13,923,000 | 13,191,000 | 19,998,000 | 16,311,000 | 16,653,000 | 20,664,000 | 16,809,000 | 14,160,000 | 16,446,000 | 20,147,000 | 20,499,000 | 16,973,000 |
| Group/Directors Accounts | 162,849,000 | 130,603,000 | 212,785,000 | 246,304,000 | 242,249,000 | 93,446,000 | 113,194,000 | 188,848,000 | 206,110,000 | 190,907,000 | 146,784,000 | 141,872,000 | 107,815,000 | 188,332,000 | 435,168,000 |
| other short term finances | 19,000 | 38,000 | 175,000 | 24,000 | 27,000 | 223,000 | |||||||||
| hp & lease commitments | 475,000 | 454,000 | 18,000 | 415,000 | 671,000 | ||||||||||
| other current liabilities | 25,796,000 | 19,938,000 | 17,772,000 | 16,572,000 | 16,438,000 | 28,402,000 | 31,073,000 | 35,667,000 | 37,567,000 | 30,326,000 | 30,410,000 | 34,570,000 | 35,222,000 | 46,382,000 | 29,326,000 |
| total current liabilities | 201,670,000 | 169,080,000 | 248,863,000 | 277,214,000 | 272,573,000 | 141,873,000 | 160,801,000 | 241,168,000 | 264,341,000 | 239,542,000 | 191,354,000 | 192,888,000 | 163,184,000 | 255,863,000 | 481,467,000 |
| loans | |||||||||||||||
| hp & lease commitments | 575,000 | 563,000 | 754,000 | ||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 16,382,000 | ||||||||||||||
| provisions | 178,733,000 | 133,446,000 | 185,044,000 | 126,599,000 | 128,663,000 | 142,302,000 | 34,302,000 | 41,989,000 | 37,610,000 | 38,341,000 | 52,550,000 | 59,963,000 | 63,708,000 | 102,677,000 | 110,776,000 |
| total long term liabilities | 179,308,000 | 134,009,000 | 185,798,000 | 126,599,000 | 145,045,000 | 142,302,000 | 34,302,000 | 41,989,000 | 41,692,000 | 48,366,000 | 68,518,000 | 81,875,000 | 90,138,000 | 135,397,000 | 147,898,000 |
| total liabilities | 380,978,000 | 303,089,000 | 434,661,000 | 403,813,000 | 417,618,000 | 284,175,000 | 195,103,000 | 283,157,000 | 306,033,000 | 287,908,000 | 259,872,000 | 274,763,000 | 253,322,000 | 391,260,000 | 629,365,000 |
| net assets | 759,799,000 | 484,124,000 | 463,306,000 | 391,394,000 | 263,451,000 | 659,581,000 | 736,967,000 | 700,946,000 | 672,373,000 | 650,787,000 | 636,782,000 | 639,079,000 | 815,011,000 | 833,481,000 | 697,929,000 |
| total shareholders funds | 759,799,000 | 484,124,000 | 463,306,000 | 391,394,000 | 263,451,000 | 659,581,000 | 736,967,000 | 700,946,000 | 672,373,000 | 650,787,000 | 636,782,000 | 639,079,000 | 815,011,000 | 833,481,000 | 697,929,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 120,540,000 | 125,926,000 | 56,169,000 | 32,038,000 | 2,538,000 | -84,706,000 | 32,018,000 | 9,376,000 | 10,052,000 | 783,000 | -19,931,000 | -62,231,000 | -36,975,000 | 38,967,000 | -134,188,000 |
| Depreciation | 480,000 | 568,000 | 972,000 | 1,112,000 | 6,327,000 | 31,406,000 | 17,237,000 | 10,844,000 | 13,915,000 | 16,478,000 | 18,267,000 | 22,202,000 | 25,336,000 | 32,616,000 | 32,543,000 |
| Amortisation | 1,822,000 | 1,654,000 | 2,127,000 | 5,787,000 | 7,138,000 | 7,210,000 | 6,940,000 | 5,563,000 | 3,314,000 | 25,000 | |||||
| Tax | 47,063,000 | -25,000 | -199,000 | -250,000 | -650,000 | -881,000 | 18,404,000 | -18,760,000 | 2,480,000 | ||||||
| Stock | 1,816,000 | 1,024,000 | -105,000 | -1,100,000 | -6,773,000 | -364,000 | -464,000 | -177,000 | 15,000 | -987,000 | -3,681,000 | -3,415,000 | 2,164,000 | 4,609,000 | 12,457,000 |
| Debtors | -138,945,000 | -109,978,000 | 104,703,000 | 169,726,000 | -246,331,000 | 46,747,000 | -33,741,000 | 26,033,000 | 29,622,000 | 51,441,000 | -3,478,000 | -132,812,000 | -135,100,000 | 119,968,000 | 851,176,000 |
| Creditors | -5,516,000 | -66,000 | 4,190,000 | 732,000 | -6,807,000 | 3,687,000 | -342,000 | -4,011,000 | 3,855,000 | 2,649,000 | -2,286,000 | -3,701,000 | -352,000 | 3,526,000 | 16,973,000 |
| Accruals and Deferred Income | 5,858,000 | 2,166,000 | 1,200,000 | 134,000 | -11,964,000 | -2,671,000 | -4,594,000 | -1,900,000 | 7,241,000 | -84,000 | -4,160,000 | -652,000 | -11,160,000 | 17,056,000 | 29,326,000 |
| Deferred Taxes & Provisions | 45,287,000 | -51,598,000 | 58,445,000 | -2,064,000 | -13,639,000 | 108,000,000 | -7,687,000 | 4,379,000 | -731,000 | -14,209,000 | -7,413,000 | -3,745,000 | -38,969,000 | -8,099,000 | 110,776,000 |
| Cash flow from operations | 352,663,000 | 187,604,000 | 18,505,000 | -130,912,000 | 236,697,000 | 16,543,000 | 77,777,000 | -1,605,000 | 7,810,000 | -45,062,000 | -9,014,000 | 87,219,000 | 89,220,000 | -59,271,000 | -805,723,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 441,676,000 | -2,000 | -6,803,000 | -2,673,000 | -1,363,000 | -204,832,000 | 251,933,000 | ||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 32,246,000 | -82,182,000 | -33,519,000 | 4,055,000 | 148,803,000 | -19,748,000 | -75,654,000 | -17,262,000 | 15,203,000 | 44,123,000 | 4,912,000 | 34,057,000 | -80,517,000 | -246,836,000 | 435,168,000 |
| Other Short Term Loans | -19,000 | -137,000 | 175,000 | -24,000 | -3,000 | -196,000 | 223,000 | ||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | 33,000 | 245,000 | 357,000 | -256,000 | 671,000 | ||||||||||
| other long term liabilities | -16,382,000 | 16,382,000 | |||||||||||||
| share issue | |||||||||||||||
| interest | 43,821,000 | 883,000 | -3,806,000 | -578,000 | 38,000 | 3,722,000 | 139,000 | 19,195,000 | 6,643,000 | 8,069,000 | 6,408,000 | -1,029,000 | -6,401,000 | 80,018,000 | 29,199,000 |
| cash flow from financing | 386,232,000 | -77,187,000 | -31,331,000 | 19,650,000 | 168,459,000 | -13,709,000 | -65,818,000 | 1,322,000 | 11,608,000 | 52,135,000 | 17,774,000 | 32,220,000 | -85,802,000 | -165,690,000 | 1,188,633,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 10,000 | 3,000 | -499,000 | -4,919,000 | -1,101,000 | 490,000 | 17,000 | -162,000 | 177,000 | -57,000 | 6,003,000 | 77,000 | -496,000 | 382,000 | 148,000 |
| overdraft | -1,500,000 | 1,500,000 | -650,000 | 650,000 | |||||||||||
| change in cash | 10,000 | 3,000 | -499,000 | -4,919,000 | -1,101,000 | 490,000 | 17,000 | -162,000 | 1,677,000 | -1,557,000 | 6,003,000 | 77,000 | 154,000 | -268,000 | 148,000 |
ge healthcare limited Credit Report and Business Information
Ge Healthcare Limited Competitor Analysis
Perform a competitor analysis for ge healthcare limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mega companies, companies in HP8 area or any other competitors across 12 key performance metrics.
ge healthcare limited Ownership
GE HEALTHCARE LIMITED group structure
Ge Healthcare Limited has 2 subsidiary companies.
Ultimate parent company
GENERAL ELECTRIC COMPANY
#0001064
2 parents
GE HEALTHCARE LIMITED
01002610
2 subsidiaries
ge healthcare limited directors
Ge Healthcare Limited currently has 4 directors. The longest serving directors include Mr Kevin O'Neill (Jan 2008) and Ms Tricia Clark (Mar 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Kevin O'Neill | United Kingdom | 56 years | Jan 2008 | - | Director |
| Ms Tricia Clark | United States | 48 years | Mar 2017 | - | Director |
| Ms Federica Conci | United Kingdom | 52 years | Apr 2023 | - | Director |
| Mr Darran Mountjoy | United Kingdom | 59 years | Oct 2023 | - | Director |
P&L
December 2023turnover
118.8m
+21%
operating profit
120.5m
-4%
gross margin
42%
-15.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
759.8m
+0.57%
total assets
1.1b
+0.45%
cash
73k
+0.16%
net assets
Total assets minus all liabilities
ge healthcare limited company details
company number
01002610
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
February 1971
age
54
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
amersham plc (February 2005)
nycomed amersham plc (July 2001)
See moreaccountant
-
auditor
DELOITTE LLP
address
pollards wood nightingales lane, chalfont st. giles, buckinghamshire, HP8 4SP
Bank
-
Legal Advisor
-
ge healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to ge healthcare limited. Currently there are 0 open charges and 1 have been satisfied in the past.
ge healthcare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GE HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
ge healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
